Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer

Our study aimed to compare the efficacy and safety of nab-paclitaxel plus cisplatin (AP) with nab-paclitaxel plus gemcitabine (AG) in patients with metastatic breast cancer (MBC). We collected data from two single-arm, phase II MBC studies. In NCT01149798, seventy-three MBC patients received 125 mg/...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi, Zhao, Yannan, Gong, Chengcheng, Xie, Yizhao, Hu, Xichun, Zhang, Jian, Wang, Leiping, Zhang, Sheng, Cao, Jun, Tao, Zhonghua, Wang, Biyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400896/
https://www.ncbi.nlm.nih.gov/pubmed/30837503
http://dx.doi.org/10.1038/s41598-019-39314-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400896/
https://www.ncbi.nlm.nih.gov/pubmed/30837503
http://dx.doi.org/10.1038/s41598-019-39314-y

Ejemplares similares